Pages

Customer SpotlightAmgen on Antibody Discovery and Cell Line Development CUSTOMER QUOTE“In the long run, this technology will help us to solve complex problems that are too hard or expensive to solve with our current tools.” — Philip Tagari, Vice President of Therapeutic Discovery, Amgen TRANSFORMATIVE TECHNOLOGY As one of the early customers to have adopted

Customer SpotlightCatalent Biologics on Cell Line Development MEET CatalentGet “True” Productivity By incorporating the Beacon system into their process, Catalent reduced their timeline and generated better clones by having more clones screened and providing them with better initial estimates of “true” productivity prior to scaling up the cell lines for production. In Catalent’s Application Note,

Customer SpotlightGenovac on Antibody Discovery MEET GenovacGoing Where Hybridoma Can’t In the recent webinar, Tackle Difficult Targets by Accessing Broad B Cell Diversity, Genovac demonstrated how the Opto™ Plasma B Discovery workflow can yield up to 10-times more hits than hybridoma campaigns against difficult membrane targets like GPCRs and other multi-pass transmembrane targets. The three

Customer SpotlightAbveris on Antibody Discovery MEET ABVERISRapid End-to-End Antibody Discovery Abveris is an antibody discovery partner with a focus on challenging therapeutic targets. They provide comprehensive gene-to-antibody discovery services by applying advanced immunization methods combined with B cell screening and hybridoma-based antibody discovery technologies. In order to reduce their timelines and discover antibodies against difficult

Customer SpotlightMedical College of Wisconsin on T Cell Characterization Medical College of WisconsinIdentifying the Biological Properties of Car T Cells That Favor Tumor Killing Using the Lighting™ Single Cell System Listen in on Dr. Anthony Zamora’s talk from CAR-TCR Summit 2021. Dr. Zamora covers topics, including:  Identifying how modifications in CAR T cell manufacturing can